Express Pharma

When health data crosses borders, trust must travel with it 

Pradeep Gupta, Partner, Deloitte India, explores how the DPDP Act, 2023, and DPDP Rules, 2025, are reshaping health data governance and why building trust must go hand in hand with enabling cross-border healthcare and research 

0 8

The framework of India’s Digital Personal Data Protection (DPDP) is currently reshaping how hospitals, pharmaceutical companies, Clinical Research Organisations (CROs), insurers and research institutions collect, process and share health data, making governance and accountability integral to healthcare and clinical research. This happens in parallel to raising the stakes for inadequate data protection and breach preparedness. 

Health records travel with patients as they cross national borders, and accordingly, Personally Identifiable Information (PII) is also shared with overseas healthcare stakeholders. 

The digital health database in India shows a rise in Medical Value Travel (MVT), which is about 5.5 per cent of all foreign tourist arrivals. As more than 450,000 patients from other countries travel to India each year, the medical tourism industry is projected to grow by $16.21 billion by 2030, posting a CAGR of 13.23 per cent. The AYUSH market is also poised to grow and is expected to reach $200 billion. Concurrently, the rising trends in the medical tourism industry reflect the growing demand for advanced clinical care and preventive wellness in India. 

Such dynamic expansion of the digital health ecosystems results in the exchange of large volumes of health information among patients, healthcare providers, insurers, CROs, pharma companies and international partners. 

The growth of medical tourism, cross-border healthcare services and global clinical research also increases the movement of sensitive personal health data across jurisdictions, highlighting the importance of resilient privacy, security and governance safeguards. 

This is where India’s DPDP Act, 2023 and the DPDP Rules, 2025 come into the picture by providing a legal and operational framework to process digital personal data and protect the information of domestic and international patients. 

As healthcare moves towards interoperable digital records, privacy, security and informed consent become the primary concerns of hospitals, health-tech firms, insurers, labs and pharma companies for the responsible use of patient centric health information. This is done by implementing access controls, consent tools and breach response plans. Penalties of $2.5 billion for failure to implement security safeguards and $2 billion for failure to report a breach in India are consequences of the DPDP Act’s robust implementation framework. 

Anonymised health data supports disease tracking, monitoring of public health trends and the design of targeted health programmes. The scale is massive with over 1.2 billion linked health records, over 980 million ABHA IDs, over 1.2 million Healthcare Professionals Registries (HPRs) of medical professionals and over 500,000 verified Health Facility Registries (HFRs) as of October 2026, showing the growing digital footprint of India’s domestic healthcare ecosystem. 

This showcases the government’s shift from policymaking to establishing an environment of trust and accountability to operationalise digital personal data governance at scale. A critical component of this trust is to make sure that data subjects can participate meaningfully in the ecosystem through accessible and inclusive engagement. 

Inclusivity 

While inclusivity drives engagement, strict adherence to jurisdictional boundaries ensures that this expanded access does not compromise national data sovereignty. Privacy notices and consent mechanisms need to be accessible in vernacular languages as an important part of the DPDP compliance. The BHASHINI app, for instance, supports 36+ Indian languages, 350+ AI models and 23+ language services. This helps to make privacy information and consent processes more accessible and inclusive for India’s citizens. 

Cross-border transfer responsibility 

Organisations should proactively map cross-border data flows, conduct Data Protection Impact Assessments (DPIAs) and strengthen contractual safeguards to ensure that every international transfer is necessary, secure and compliant. DPDP Rules permit the government to restrict transfers of personal data to specified foreign states. DPIA can help identify and share essential datasets for clinical research. Contracts with pharmaceutical companies and CROs, sponsors, insurers, cloud providers, etc., should govern secondary use, onward transfers, security standards, subprocessors and timely incident reporting. 

Breach preparedness

Organisations should move beyond reactive breach management by strengthening incident response readiness and investing strategically in Privacy Enhancing Technologies (PETs). This will help build resilience, reduce privacy risks and embed privacy by design into their data ecosystem. The DPDP Rules, 2025, establish clear requirements for breach notification, with Rule 7 requiring data fiduciaries to notify the Data Protection Board within 72 hours, unless an extension is permitted. This highlights the necessity for organisations to establish and operationalise robust breachresponse mechanisms well in advance. 

Compliance obligation 

Healthcare organisations should treat data protection as a strategic priority, implementing privacy, security and responsible data governance into digital healthcare initiatives from the outset to build trust and unlock sustainable growth. Rapid expansion of India’s digital infrastructure adds urgency to this transition since the scale and sensitivity of personal health data requires protection, as Internet subscriptions surpass one billion, mobile connectivity in 98 per cent of villages, covering more than 470,000 5G towers in 99.6 per cent of districts.  

For clinical research, medical tourism and cross-border health data exchange, the DPDP Act, 2023, and the DPDP Rules, 2025, provide the guardrails for how personal health data should be handled, protected and shared. Their impact, however, will be determined by how consistently hospitals, pharmaceutical companies, CROs, insurers and research institutions translate these requirements into everyday decisions on consent, access, security and accountability. When health data crosses borders, trust cannot be assumed; it must be demonstrated at every stage of the data journey.

 

Leave A Reply

Your email address will not be published.